Rosanna Tarricone
Associate Professor
Biography
Rosanna Tarricone is Associate Dean of the SDA Bocconi School of Management - Government, Health and Non-Profit Division and Associate Professor at the Department of Social and Political Sciences, Università Bocconi. She graduated in Business Administration at Università Bocconi and continued her studies at the University of London - London School of Hygiene and Tropical Medicine, where she obtained an MSc in Health Services Management and a PhD in Public Health and Policy.
Rosanna has over 100 publications in the areas of health policy, health management, economic evaluation and Health Technology Assessment (HTA).
In the last 10 years Rosanna has won over 10 competitive research grants from international organisations such as the European Union, the Swiss Bridge Award and InHealth (USA). She is leader of HEU-EFS, a large, multi-year, international, EU-funded research project that aims to develop a programme of Early Feasibility Studies for the European Union.
Rosanna is among the experts collaborating with DG Research and DG Health of the European Commission. She facilitated the exchange of experience and harmonisation of methods and procedures between the HTA Agencies of the EU Member States that joined EUnetHTA (European network of HTA Agencies). Since 2022 Rosanna has been a member of the AGENAS Working Group on Telemedicine, is a member of the European Task Force on Digital Technologies and collaborates with the National Observatory on Antibiotic Resistance. She contributed to designing and developing the National HTA Programme of Medical Devices for the Ministry of Health and since 2024, she is part of the Steering Committee of the National Plan for High Technology Agriculture (PNHTA).
Between 2005 and 2010 Rosanna held the position of Director of Economic Affairs of Medtech Europe (the European association of medical technology companies) and helped develop research programmes and generate solid evidence on medical devices through the launch of the European Health Technology Institute for Socio-Economic Research, a partnership between European universities (Università Bocconi, London School of Economics and Technische Universität Berlin) and policy makers (European Commission, WHO).
Rosanna is an active member of ISPOR - International Society of Health Economics and Outcome Research (HEOR) and served on the Board of Directors during 2016-2018. She led the Publications Management Advisory Board (MAB) in 2018-2019 and developed the scientific programme for the international conference in New Orleans in 2019 "Rapid. Disruptive. Innovative: A New Era in HEOR".
Recent Publications
- 2025
Il futuro della sanità pubblica dipende anche da noi
TARRICONE, R., "Il futuro della sanità pubblica dipende anche da noi", Il Corriere della Sera, 26 January 2025 - 2025
Economic Evaluations of Health Service Interventions Targeting Patients with Multimorbidities: A Scoping Literature Review
FERRARA, L., V. ARDITO, V. TOZZI, R. TARRICONE, "Economic Evaluations of Health Service Interventions Targeting Patients with Multimorbidities: A Scoping Literature Review", International Journal of Integrated Care, 2025, vol. 25, pp. 3 - 2025
Economic Value of Enhanced Monofocal Intraocular Lenses for Cataract Surgery in Italy
ROGNONI, C., I. GIABBANI, M. BALESTRIERI, G. COSTA, E. FAVUZZA, R. GIGLIO, R. MENCUCCI, G. STAURENGHI, L. TARONI, D. TOGNETTO, R. TARRICONE, "Economic Value of Enhanced Monofocal Intraocular Lenses for Cataract Surgery in Italy", Clinical Therapeutics, 2025, vol. 47, no. 5, pp. 363-370 - 2025
Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context
ROGNONI, C., V. ARDITO, D. LA FAUCI, M. PIERI, A. M. SCANDROGLIO, R. TARRICONE, "Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context", Cardiology and Therapy, 2025, vol. 14, pp. 183–198 - 2025
A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia—results from a multi-stakeholder workshop
AL-OMAR, H. A., A. A. ALMUHSIN, L. H. ALMUDAIYAN, A. H. AL-NAJJAR, L. C. ABU ESBA, H. ALMODAIMEGH, E. S. ALTAWIL, C. C. YOUSEF, M. A. KHAN, K. AL-YAHYA, J. ALAMRE, F. MARAIKI, J. ESPÍN, R. TARRICONE, P. KANAVOS, "A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia—results from a multi-stakeholder workshop", Journal of Medical Economics, 2025, vol. 28, no. 1, pp. 753-765 - 2025
In una logica life cycle
TARRICONE, R., "In una logica life cycle", Panorama della Sanità, June 2025, pp. 32-34 - 2025
A mobile supportive care app for patients with metastatic lung cancer: the Lung Cancer App (LuCApp) randomized controlled trial
PONGIGLIONE, B., M. CUCCINIELLO, F. PETRACCA, O. CIANI, S. NOVELLO, M. MIGLIORINO, P. PEDRAZZOLI, F. AGUSTONI, G. LO RUSSO, R. TARRICONE, E. CAPELLETTO, "A mobile supportive care app for patients with metastatic lung cancer: the Lung Cancer App (LuCApp) randomized controlled trial", Supportive Care in Cancer, 2025, vol. 33, pp. 641 - 2025
Harnessing financial incentives for health promotion: A scoping review of prevention programs implemented in upper-middle and high-income countries
PETRACCA, F., V. ARDITO, F. SALA, G. BERTOLASO, L. MENICHELLI, R. VECCHIO, R. TARRICONE, "Harnessing financial incentives for health promotion: A scoping review of prevention programs implemented in upper-middle and high-income countries", Social Science & Medicine, 2025, vol. 383, pp. 118499 - 2025
LuCApp and cancer patients: Benefits and limits of digital technologies - LuCApp e pazienti oncologici: benefici e limiti delle tecnologie digitali
CIANI, O., M. CUCCINIELLO, F. PETRACCA, R. TARRICONE, "LuCApp and cancer patients: Benefits and limits of digital technologies - LuCApp e pazienti oncologici: benefici e limiti delle tecnologie digitali", SDA Bocconi Insight, 22 September 2025 - 2025
The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States
ARSENAULT, C., S. RAVISHANKAR, T. LEWIS, P. ARMENI, K. CROKE, S. V. DOUBOVA, M. MCKEE, R. TARRICONE, M. E. KRUK, "The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States", Vaccine, 2025, vol. 54, pp. 127134
You have seen 10 out of 272 items
Grants & Honors
Servizio di ricerca e sviluppo per la realizzazione del progetto “Sanità 2.0” - Direzione Generale della Programmazione Sanitaria, Ministero Della Salute, 2019
Valutazione dell’impatto in termini organizzativi ed economici dell’upgrade di classificazione dei dispositivi medici a seguito dell’applicazione delle nuove regole previste dai Regolamenti (UE) 2017/745 e 2017/746, in relazione alla peculiare configurazione del settore produttivo italiano - - Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico, Ministero Della Salute, 2018
Valutazione dell’impatto organizzativo ed economico delle nuove esigenze di programmazione, progettazione e conduzione delle indagini cliniche sui dispositivi medici, a seguito dell’applicazione del Regolamento (UE) 2017/745 - Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico, Ministero Della Salute, 2018
Valutazione di impatto delle attività derivanti dagli adempimenti previsti dai nuovi Regolamenti 745 e 746 del 2017 a carico degli operatori economici, degli sponsor di indagini cliniche, degli operatori sanitari e dell’autorità competente per i dispositivi medici. Individuazione di metodologie di analisi al fine della valutazione di determinanti sui costi dei dispositivi medici - Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico, Ministero Della Salute, 2018
Individuazione di metodologie di analisi degli eventi avversi, sia in fase pre-market che in fase post-market, utilizzando le nuove classificazioni sviluppate nell’ambito del “International Medical Device Regulators Forum- IMDRF” al fine della valutazione di determinanti della variabilità dei costi - Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico, Ministero Della Salute, 2018
H2020 – COMED Pushing the boundaries of cost and outcome analysis of medical technologies. Leading coordinator, European Commission, 2018
IMPACT – HTA Improved methods and actionable tools for enhancing HTA. WP Co-leader, European Commission, 2018
Teaching Excellence Award, Università Commerciale Luigi Bocconi, 2016
Teaching Excellence Award, Università Commerciale Luigi Bocconi, 2014
MAPPING NCDs: Mapping Chronic Non-Communicable Diseases Research Activities and their Impact. WP Coordinator, European Commission, 2013
FP7 - MedtecHTA: Methods for Health Technology Assessment of Medical Devices: A European Perspective, Project Leader, European Commission, 2013
Best Instructor of Specialised Masters Award - Masters Division, SDA Bocconi School of Management, 2013
Teaching Excellence Award, Università Commerciale Luigi Bocconi, 2013
